This result goes in line with the data retrieved from TCGA-GBM dataset (at http://gliovis.bioinfo.cnio.es/, accessed on 1 February 2022) that indicate a significant increase of cry1 mRNA levels (RNA-seq) in GB samples, as compared to non-tumor tissue. This evidence concerns the gene CRY1 and glioblastoma.